Technology area: Biotechnology & Pharmaceuticals
12 pending office actions • 6 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
STEMCELL Technologies Canada Inc. manages a portfolio in the Biotechnology & Pharmaceuticals technology area, characterized by 11 pending office actions. These actions are distributed among 11 distinct examiners, indicating a broad engagement with patent office personnel. The portfolio is currently active across 6 distinct art units, which suggests a range of subject matter within the biotechnology sector.
BEHARRY, ZANNA MARIA is the busiest examiner for the company, though this examiner is only responsible for 1 pending office action. This distribution is notable because the 11 pending office actions are spread across 11 examiners, meaning no single examiner holds a majority of the workload. With 11 distinct examiners and 6 distinct art units, the company faces a variety of examination styles and art unit timelines. This level of activity provides a significant amount of data for comparing prosecution experiences across different segments of the Biotechnology & Pharmaceuticals field. The high number of distinct examiners relative to the 11 pending actions indicates a decentralized prosecution environment.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (25%) |
| §112 only | 1 (8%) |
| Double-patenting + other | 5 (42%) |
| Multi-statute (no §101) | 3 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NASHER, AHMED ABDULLALIM-M | 1 | 79.1% | +32.5% |
| BEHARRY, ZANNA MARIA | 1 | 24.7% | +56.4% |
| MARCSISIN, ELLEN JEAN | 1 | 34.5% | +49.3% |
| CANDELARIA, JULIANA IRENE | 1 | 0.0% | +0.0% |
| KASAYAN, KATRIEL BARCELLANO | 1 | 25.0% | +0.0% |
| SCHUBERG, LAURA J | 1 | 23.6% | +37.0% |
| LEITH, NANCY J | 1 | 74.7% | +44.1% |
| VIVLEMORE, TRACY ANN | 1 | 73.0% | +6.6% |
| MATALKAH, FATIMAH KHALAF | 1 | 54.8% | +28.6% |
| KWAK, DEAN P | 1 | 58.7% | +37.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18569259 | COMPOSITIONS AND METHODS FOR BIASING THE POLARITY OF ORGANOIDS | KASAYAN, KATRIEL BARCELLANO | 6d |
| 18555332 | MEDIA AND METHODS FOR GROWING MAMMARY ORGANOIDS | SCHUBERG, LAURA J | 40d |
| 18726305 | MODIFIED HEMATOPOIETIC STEM CELLS AND USES THEREOF | BEHARRY, ZANNA MARIA | — |
| 18718866 | COMPOSITIONS AND METHODS FOR EXPANDING KERATINOCYTES | CANDELARIA, JULIANA IRENE | — |
| 17562821 | MICROFLUIDIC CHIP HAVING INCREASED THROUGHPUT FOR USE IN A SYSTEM FOR DELIVERY OF A PAYLOAD INTO A CELL | KWAK, DEAN P | — |
| 17425709 | ANUCLEATE CELL-DERIVED VACCINES | RIGA, MICHAEL ANGELO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18555332 | MEDIA AND METHODS FOR GROWING MAMMARY ORGANOIDS | SCHUBERG, LAURA J | 40d |
| 19032526 | SYSTEMS, METHODS AND APPARATUS FOR THE AUTOMATED CULTURE OF CELLS | NASHER, AHMED ABDULLALIM-M | — |
| 18726305 | MODIFIED HEMATOPOIETIC STEM CELLS AND USES THEREOF | BEHARRY, ZANNA MARIA | — |
| 18750208 | COMPOSITIONS AND METHODS FOR RAPID AND REVERSIBLE BIOMOLECULAR LABELING | MARCSISIN, ELLEN JEAN | — |
| 18190335 | INTRACELLULAR DELIVERY OF BIOMOLECULES TO CELLS COMPRISING A CELL WALL | LEITH, NANCY J | — |
| 17779830 | DEVICES, METHODS AND ASSAYS FOR BIOLOGICAL MATERIALS | MATALKAH, FATIMAH KHALAF | — |
| 17562821 | MICROFLUIDIC CHIP HAVING INCREASED THROUGHPUT FOR USE IN A SYSTEM FOR DELIVERY OF A PAYLOAD INTO A CELL | KWAK, DEAN P | — |
| Art Unit | Apps |
|---|---|
| 1634 | 2 |
| 1638 | 2 |
| 1631 | 1 |
| 1636 | 1 |
| 1798 | 1 |
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19032526 | SYSTEMS, METHODS AND APPARATUS FOR THE AUTOMATED CULTURE OF CELLS | NASHER, AHMED ABDULLALIM-M | — | §103DP | Non-Final OA | — | Pending | Jan 21, 2025 |
| 18726305 | MODIFIED HEMATOPOIETIC STEM CELLS AND USES THEREOF | BEHARRY, ZANNA MARIA | — | §102§103§112DP | Non-Final OA | — | Pending | Jul 02, 2024 |
| 18750208 | COMPOSITIONS AND METHODS FOR RAPID AND REVERSIBLE BIOMOLECULAR LABELING | MARCSISIN, ELLEN JEAN | — | §103§112DP | Non-Final OA | — | Pending | Jun 21, 2024 |
| 18718866 | COMPOSITIONS AND METHODS FOR EXPANDING KERATINOCYTES | CANDELARIA, JULIANA IRENE | — | §103§112 | Non-Final OA | — | Pending | Jun 12, 2024 |
| 18569259 | COMPOSITIONS AND METHODS FOR BIASING THE POLARITY OF ORGANOIDS | KASAYAN, KATRIEL BARCELLANO | 1634 | §103 | Final Rejection | 6d | Pending | Dec 12, 2023 |
| 18555332 | MEDIA AND METHODS FOR GROWING MAMMARY ORGANOIDS | SCHUBERG, LAURA J | 1631 | §103 | Final Rejection | 40d | Pending | Oct 13, 2023 |
| 18190335 | INTRACELLULAR DELIVERY OF BIOMOLECULES TO CELLS COMPRISING A CELL WALL | LEITH, NANCY J | 1636 | §112DP | Non-Final OA | — | Pending | Mar 27, 2023 |
| 17822942 | INTRACELLULAR DELIVERY OF COMPLEXES | VIVLEMORE, TRACY ANN | 1638 | §112 | Non-Final OA | — | Pending | Aug 29, 2022 |
| 17779830 | DEVICES, METHODS AND ASSAYS FOR BIOLOGICAL MATERIALS | MATALKAH, FATIMAH KHALAF | 1638 | §103 | Final Rejection | — | Pending | May 25, 2022 |
| 17562821 | MICROFLUIDIC CHIP HAVING INCREASED THROUGHPUT FOR USE IN A SYSTEM FOR DELIVERY OF A PAYLOAD INTO A CELL | KWAK, DEAN P | 1798 | §102§103 | Final Rejection | — | Pending | Dec 27, 2021 |
| 17425709 | ANUCLEATE CELL-DERIVED VACCINES | RIGA, MICHAEL ANGELO | 1634 | §102§103§112Other | Non-Final OA | — | Pending | Jul 23, 2021 |
| 17282709 | INTRACELLULAR DELIVERY OF BIOMOLECULES TO ENHANCE ANTIGEN PRESENTING CELL FUNCTION | JUEDES, AMY E | 1644 | §103§112DP | Non-Final OA | — | Pending | Apr 02, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial